Variant report
Variant | esv275351 |
---|---|
Chromosome Location | chr14:63326784-63332083 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546411048 | chr14:63327414-63327415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11851853 | chr14:63327434-63327435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559946665 | chr14:63327463-63327464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150980521 | chr14:63327489-63327490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542275462 | chr14:63327501-63327502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1106722 | chr14:63327546-63327547 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs530911975 | chr14:63327598-63327599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544324886 | chr14:63327599-63327600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187343736 | chr14:63327619-63327620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191349905 | chr14:63327665-63327666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11851939 | chr14:63327676-63327677 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs113731851 | chr14:63327695-63327696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79771570 | chr14:63327772-63327773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs377225144 | chr14:63327786-63327787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528289463 | chr14:63327850-63327851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548253102 | chr14:63327874-63327875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568093368 | chr14:63327883-63327884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537047792 | chr14:63327894-63327895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556724558 | chr14:63327914-63327915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183928634 | chr14:63327947-63327948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540092211 | chr14:63327987-63327988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575090919 | chr14:63327990-63327991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112072677 | chr14:63327991-63327992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79363233 | chr14:63328004-63328005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531590254 | chr14:63328009-63328010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553717545 | chr14:63328041-63328042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573458673 | chr14:63328042-63328043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116890856 | chr14:63328069-63328070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10143260 | chr14:63328096-63328097 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs575686669 | chr14:63328100-63328101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113270723 | chr14:63328162-63328163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564090159 | chr14:63328188-63328189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533179835 | chr14:63328204-63328205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201838095 | chr14:63328272-63328273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545662000 | chr14:63328273-63328274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561928394 | chr14:63328276-63328277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187772520 | chr14:63328312-63328313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531035444 | chr14:63328318-63328319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375817067 | chr14:63328319-63328320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11621432 | chr14:63328337-63328338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111265844 | chr14:63328352-63328353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs370841057 | chr14:63328355-63328356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368267105 | chr14:63328356-63328357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77920521 | chr14:63328371-63328372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs193097664 | chr14:63328391-63328392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs3046137 | chr14:63328393-63328394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374748800 | chr14:63328430-63328431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77666900 | chr14:63328441-63328442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530482388 | chr14:63328473-63328474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550699514 | chr14:63328475-63328476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Leukemia | 18688285 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:63327400-63328000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr14:63328000-63328400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr14:63328400-63328800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr14:63331200-63332600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr14:63331200-63332600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr14:63331400-63331800 | Enhancers | Brain Germinal Matrix | brain |
7 | chr14:63331400-63332000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr14:63331400-63332000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr14:63331400-63332000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr14:63331400-63332000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr14:63331400-63332400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr14:63331400-63332600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr14:63331600-63332000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr14:63331600-63332000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr14:63331600-63332000 | Enhancers | H9 Cell Line | embryonic stem cell |
16 | chr14:63331600-63332000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr14:63331600-63332200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr14:63331600-63332400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |